Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality.
Goldstein DJ, Seldomridge JA, Chen JM, Catanese KA, DeRosa CM, Weinberg AD, Smith CR, Rose EA, Levin HR, Oz MC.
Goldstein DJ, et al. Among authors: weinberg ad.
Ann Thorac Surg. 1995 May;59(5):1063-7; discussion 1068. doi: 10.1016/0003-4975(95)00086-z.
Ann Thorac Surg. 1995.
PMID: 7537489
Free article.
Clinical Trial.